glp-1 and family history of thyroid cancer GLP1 medications have led to increased risk medullary in rodents therefore should not be used in those with a personal or of medullary thyroid cancer or MEN2 GLP-1 receptor agonist use for

In October, a compounding industry group, the Outsourcing Facility Association, filed a lawsuit against the FDA's decision that there was no longer a shortage of tirzepatide, the active ingredient fin Zepbound and Mounjaro

If youre considering weight loss medicine, its important to understand who qualifies for GLP-1s.* These medications are intended for people with type 2 diabetes and obesity

Gallups survey found nearly 70% of current GLP-1 users take FDA-approved brand-name medications, compared with 19% using the generally cheaper, compounded versions

Are there specific blood tests (like thyroid, iron, or hormone panels) we should run to rule out other causes